#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15482	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2171	709.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1410	1410	C	913	C	863	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29008	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3668	788.9	0	.	n	.	0	T695C	SNP	695	695	T	1088	1088	C	903	C,T	858,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29008	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3668	788.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1730	1730	A	932	A	881	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29008	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3668	788.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2364	2364	C	945	C,T,G	876,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29008	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3668	788.9	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2990	2990	T	891	T,C	845,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29008	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3668	788.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2438	2438	A	949	A	901	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1568	folP	858	858	91.61	folP.l15.c4.ctg.1	1536	101.6	0	.	p	.	0	V36A	NONSYN	106	108	GTG	517	519	GCG	194;195;203	G;C;G	181;182;189	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1568	folP	858	858	91.61	folP.l15.c4.ctg.1	1536	101.6	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	559	561	CGG	200;200;201	C;G;G	188;188;188	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1568	folP	858	858	91.61	folP.l15.c4.ctg.1	1536	101.6	0	.	p	.	0	S68L	NONSYN	202	204	TCG	613	615	TTG	183;177;176	T;T;G	165;162;163	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1568	folP	858	858	91.61	folP.l15.c4.ctg.1	1536	101.6	0	.	p	.	0	A90V	NONSYN	268	270	GCG	679	681	GTT	179;177;174	G;T,G;T,G	163;161,1;155,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1568	folP	858	858	91.61	folP.l15.c4.ctg.1	1536	101.6	0	.	p	.	0	I105V	NONSYN	313	315	ATT	724	726	GTT	149;148;148	G;T;T	140;138;139	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1568	folP	858	858	91.61	folP.l15.c4.ctg.1	1536	101.6	0	.	p	.	0	N125T	NONSYN	373	375	AAT	784	786	ACC	150;149;148	A;C;C	136;137;139	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1568	folP	858	858	91.61	folP.l15.c4.ctg.1	1536	101.6	0	.	p	.	0	R135C	NONSYN	403	405	CGT	814	816	TGT	155;152;153	T;G;T	140;140;140	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1568	folP	858	858	91.61	folP.l15.c4.ctg.1	1536	101.6	0	.	p	.	0	K151E	NONSYN	451	453	AAA	862	864	GAA	136;136;132	G;A;A	125;125;124	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1568	folP	858	858	91.61	folP.l15.c4.ctg.1	1536	101.6	0	.	p	.	0	T152N	NONSYN	454	456	ACC	865	867	AAC	134;136;133	A;A;C	126;127;125	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1568	folP	858	858	91.61	folP.l15.c4.ctg.1	1536	101.6	0	.	p	.	0	A172T	NONSYN	514	516	GCG	925	927	ACA	123;122;123	A;C;A	114;118;119	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1568	folP	858	858	91.61	folP.l15.c4.ctg.1	1536	101.6	0	.	p	.	0	A175E	NONSYN	523	525	GCG	934	936	GAA	127;130;127	G;A;A	119;120;119	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1568	folP	858	858	91.61	folP.l15.c4.ctg.1	1536	101.6	0	.	p	.	0	E176T	NONSYN	526	528	GAA	937	939	ACC	130;131;129	A;C;C	116;123;119	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1568	folP	858	858	91.61	folP.l15.c4.ctg.1	1536	101.6	0	.	p	.	0	I178V	NONSYN	532	534	ATC	943	945	GTC	129;127;129	G;T;C	118;117;119	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1568	folP	858	858	91.61	folP.l15.c4.ctg.1	1536	101.6	0	.	p	.	0	I188T	NONSYN	562	564	ATA	973	975	ACG	140;142;140	A;C;G	130;132;131	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1568	folP	858	858	91.61	folP.l15.c4.ctg.1	1536	101.6	0	.	p	.	0	P200N	NONSYN	598	600	CCC	1009	1011	AAC	137;138;135	A;A;C	131;130;127	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1568	folP	858	858	91.61	folP.l15.c4.ctg.1	1536	101.6	0	.	p	.	0	F220L	NONSYN	658	660	TTT	1069	1071	TTG	147;150;148	T;T;G	135;139;136	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1568	folP	858	858	91.61	folP.l15.c4.ctg.1	1536	101.6	0	.	p	.	0	A239T	NONSYN	715	717	GCA	1126	1128	ACC	137;136;136	A,G;C;C,G	126,1;130;129,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1568	folP	858	858	91.61	folP.l15.c4.ctg.1	1536	101.6	0	.	p	.	0	N240D	NONSYN	718	720	AAT	1129	1131	GAC	140;141;146	G;A;C,A	135;134;140,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1568	folP	858	858	91.61	folP.l15.c4.ctg.1	1536	101.6	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1138	1140	GCG	146;146;147	G;C;G	135;114;138	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1568	folP	858	858	91.61	folP.l15.c4.ctg.1	1536	101.6	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1174	1176	GCT	122;122;123	G,T;C;T,C	114,2;115;113,2	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1568	folP	858	858	91.61	folP.l15.c4.ctg.1	1536	101.6	1	SNP	p	R230S	1	.	.	688	690	AGC	1099	1101	AGC	148;148;148	A;G;C	134;134;133	folP.Neisseria_meningitidis_MC58_v2_01707:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5296	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3427	154.0	1	SNP	p	S91F	0	.	.	271	273	TCC	529	531	TCC	198;199;199	T;C;C	187;188;187	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5296	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3427	154.0	1	SNP	p	D95N	0	.	.	283	285	GAC	541	543	GAC	202;199;201	G;A;C	191;189;190	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5296	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3427	154.0	1	SNP	p	D95G	0	.	.	283	285	GAC	541	543	GAC	202;199;201	G;A;C	191;189;190	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	1674	mtrR	633	633	100.0	mtrR.l6.c4.ctg.1	1392	119.9	1	SNP	p	G45D	1	.	.	133	135	GAC	521	523	GAC	222;224;223	G;A;C	208;211;210	mtrR.WHO_K_01388:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	868	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c17.ctg.1	880	97.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5348	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2947	181.0	1	SNP	p	D86N	0	.	.	256	258	GAC	559	561	GAC	208;208;213	G;A;C	197;194;201	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5348	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2947	181.0	1	SNP	p	S87W	0	.	.	259	261	AGT	562	564	AGT	212;211;213	A;G;T	200;203;203	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5348	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2947	181.0	1	SNP	p	S87R	0	.	.	259	261	AGT	562	564	AGT	212;211;213	A;G;T	200;203;203	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5348	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2947	181.0	1	SNP	p	S87I	0	.	.	259	261	AGT	562	564	AGT	212;211;213	A;G;T	200;203;203	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5348	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2947	181.0	1	SNP	p	S88P	0	.	.	262	264	TCC	565	567	TCC	214;216;216	T;C;C	201;203;205	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4252	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2638	160.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1449	1451	GGC	234;234;232	G,A;G;C	222,1;218;217	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4022	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2422	165.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1251	1253	GCA	220;222;221	G,A;C;A	209,1;209;209	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4022	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2422	165.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1254	1256	ATC	222;223;226	A;T;C	211;211;210	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4022	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2422	165.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1266	1268	GTG	230;230;230	G;T;G	216;216;216	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4022	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2422	165.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1266	1268	GTG	230;230;230	G;T;G	216;216;216	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4022	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2422	165.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1770	1772	ACC	188;189;190	A;C;C	168;173;175	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4022	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2422	165.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1824	1826	GCG	191;190;189	G;C,G;G	175;157,1;160	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4022	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2422	165.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1824	1826	GCG	191;190;189	G;C,G;G	175;157,1;160	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4022	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2422	165.4	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1947	1949	GGC	174;175;175	G;G;C	159;160;162	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4022	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2422	165.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1956	1958	GGC	172;170;169	G;G;C	159;154;156	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4022	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2422	165.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1974	1976	CCG	141;145;145	C,G;C,G;G	108,5;114,1;115	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5710	ponA	2397	2397	99.96	ponA.l15.c30.ctg.1	3004	189.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2142	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1825	116.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	542	542	C	168	C	150	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1527	185.4	0	.	p	.	0	G38E	NONSYN	112	114	GGA	454	456	GAA	262;263;258	G;A;A	239;241;234	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1527	185.4	0	.	p	.	0	S46G	NONSYN	136	138	AGC	478	480	GGC	242;238;236	G;G;C	230;224;222	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1527	185.4	0	.	p	.	0	E48G	NONSYN	142	144	GAA	484	486	GGA	238;240;240	G;G;A	227;226;227	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1527	185.4	0	.	p	.	0	T87A	NONSYN	259	261	ACT	601	603	GCT	215;214;215	G,A;C;T	194,1;192;191	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1527	185.4	0	.	p	.	0	T89S	NONSYN	265	267	ACC	607	609	AGC	218;215;215	A;G;C	197;192;191	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1527	185.4	0	.	p	.	0	.	MULTIPLE	358	359	AA	699	700	CG	210;212	C;G	196;198	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1527	185.4	0	.	p	.	0	.	MULTIPLE	361	362	GA	702	704	CAG	212;210;210	C;A;G	198;196;195	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1527	185.4	0	.	p	.	0	N122K	NONSYN	364	366	AAC	706	708	AAA	212;211;212	A;A;A	199;198;198	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1527	185.4	0	.	p	.	0	K143E	NONSYN	427	429	AAA	769	771	GAA	202;202;206	G;A;A	192;191;195	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1527	185.4	0	.	p	.	0	V151A	NONSYN	451	453	GTA	793	795	GCA	215;211;211	G;C;A	195;195;193	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1527	185.4	0	.	p	.	0	A215T	NONSYN	643	645	GCT	985	987	ACT	214;212;212	A;C;T	203;202;201	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1527	185.4	0	.	p	.	0	I218M	NONSYN	652	654	ATA	994	996	ATG	197;197;198	A;T;G	189;188;189	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1527	185.4	0	.	p	.	0	T256A	NONSYN	766	768	ACA	1108	1110	GCA	213;216;220	G;C;A	202;203;208	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1527	185.4	0	.	p	.	0	W257T	NONSYN	769	771	TGG	1111	1113	ACG	218;217;214	A;C;G,T	205;206;202,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1527	185.4	0	.	p	.	0	S258G	NONSYN	772	774	AGT	1114	1116	GGG	213;208;211	G;G,T;G	201;198,1;198	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1527	185.4	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1117	1119	GTT	211;209;208	G;T;T	198;195;196	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1527	185.4	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1177	1179	GTA	222;223;224	G;T;A	205;206;209	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1527	185.4	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1216	1218	ACT	240;242;243	A;C;T	217;228;225	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1527	185.4	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1222	1224	GAT	247;246;247	G;A;T	227;225;230	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1527	185.4	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1234	1236	CAC	238;232;233	C,A;A;C	220,1;216;217	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1527	185.4	1	SNP	p	G120K	1	.	.	358	360	AAG	699	701	CGG	210;212;212	C;G;G	196;198;198	porB1b.WHO_L_01891c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1527	185.4	1	SNP	p	D121N	0	.	.	361	363	GAC	702	705	CGC	212;210;209	C;G;C	198;195;195	porB1b.WHO_L_01891c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1527	185.4	1	SNP	p	A121D	1	.	.	361	363	GAC	702	705	CGC	212;210;209	C;G;C	198;195;195	porB1b.WHO_L_01891c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	11334	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4994	226.6	0	.	p	.	0	R640C	NONSYN	1918	1920	CGC	2319	2321	TGC	259;254;252	T,C;G;C	246,2;243;241	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	11334	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4994	226.6	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2058	2060	CAT	245;245;244	C;A;T	233;232;234	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1132	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	905	124.1	1	SNP	p	V57M	1	.	.	169	171	ATG	470	472	ATG	240;240;242	A;T;G	226;226;228	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
